Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (18364)	1/29/1999 7:31:00 PM
From: Mkilloran	Respond to of 23519

Vlad and Dias....Viagra scripts have been in the 160,000 range per week in the USA. If the USA had a partner that could do anywhere near what we are seeing in the UK and Sweden ...your looking at about 46,000 scripts a week for Muse. That's way beyond my dreams... But 20% gives us 32,000 a week it may be a goal that can be reached. Even if they sign a deal with a partner to supply Muse to the partner for about $7 a pellet like Astra and Janssen pay for supplies. 20% goal is worth $17 mill a qtr in domestic sales. Maybe I'am dreaming based on the UK and Sweden numbers.... We can only go up from where we are today with no partner. There are millions of men in the USA that are in high risk groups, on nitrates, other meds that contradict with Viagra, are unsuccessful using Viagra, etc to direct an effective marketing program to use MUSE. Things are taking longer than any of us would like ....